ALINT.PA Stock - IntegraGen S.A.
Unlock GoAI Insights for ALINT.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $8.70M | $12.54M | $13.17M | $11.32M | $8.98M |
| Gross Profit | $1.79M | $-6,978 | $-6,355 | $43,693 | $-89,452 |
| Gross Margin | 20.5% | -0.1% | -0.0% | 0.4% | -1.0% |
| Operating Income | $-807,000 | $-183,765 | $-139,125 | $-29,549 | $-254,138 |
| Net Income | $-256,000 | $-171,399 | $-3,507 | $15,407 | $-375,021 |
| Net Margin | -2.9% | -1.4% | -0.0% | 0.1% | -4.2% |
| EPS | $-0.04 | $-0.03 | $-0.00 | $0.00 | $-0.06 |
IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
Visit WebsiteEarnings History & Surprises
ALINT.PAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Apr 29, 2025 | — | $-0.02 | — | — |
Q4 2024 | Oct 17, 2024 | — | $-0.02 | — | — |
Q2 2024 | Apr 24, 2024 | — | $0.01 | — | — |
Q4 2023 | Oct 20, 2023 | — | $-0.04 | — | — |
Q2 2023 | Apr 24, 2023 | — | $0.02 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.02 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.06 | — | — |
Q2 2021 | Apr 19, 2021 | — | $-0.06 | — | — |
Q4 2020 | Dec 11, 2020 | — | $0.00 | — | — |
Q2 2020 | Apr 28, 2020 | — | $0.04 | — | — |
Q4 2019 | Nov 15, 2019 | — | $-0.08 | — | — |
Q2 2019 | Apr 18, 2019 | — | $-0.09 | — | — |
Q3 2018 | Sep 20, 2018 | — | $-0.08 | — | — |
Q2 2018 | Apr 13, 2018 | — | $-0.06 | — | — |
Q3 2017 | Sep 28, 2017 | — | $-0.07 | — | — |
Q2 2017 | Apr 21, 2017 | — | $-0.12 | — | — |
Q3 2016 | Aug 19, 2016 | — | $-0.20 | — | — |
Q2 2016 | Jun 6, 2016 | — | $-0.07 | — | — |
Q3 2015 | Jul 10, 2015 | — | $-0.07 | — | — |
Latest News
Frequently Asked Questions about ALINT.PA
What is ALINT.PA's current stock price?
What is the analyst price target for ALINT.PA?
What sector is IntegraGen S.A. in?
What is ALINT.PA's market cap?
Does ALINT.PA pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ALINT.PA for comparison